Publicaciones (75) Publicaciones de Jose Julio Laguna Martinez

2024

  1. EAACI/ENDA position paper on drug provocation testing

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 79, Núm. 3, pp. 565-579

2023

  1. Different Patterns of Response in Hypersensitivity Reactions to Arylpropionic Acid Derivatives

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 12, pp. 3715-3723

  2. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology

  3. Personalized diagnostic approach and indirect quantification of extravasation in human anaphylaxis

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 1, pp. 202-213

2022

  1. Allergies and COVID-19 vaccines: An ENDA/EAACI Position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 77, Núm. 8, pp. 2292-2312

  2. Making a Diagnosis in Allergic Reactions Occurring in the Operating Room

    Current Treatment Options in Allergy, Vol. 9, Núm. 4, pp. 409-427

2021

  1. Characterization of anaphylaxis reveals different metabolic changes depending on severity and triggers

    Clinical and Experimental Allergy, Vol. 51, Núm. 10, pp. 1295-1309

  2. Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID

    British Journal of Pharmacology, Vol. 178, Núm. 5, pp. 1218-1233

  3. Diagnostic Approach of Hypersensitivity Reactions to Cefazolin in a Large Prospective Cohort

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 12, pp. 4421-4430.e4

  4. Genetic Variants Associated With Drug-Induced Hypersensitivity Reactions: towards Precision Medicine?

    Current Treatment Options in Allergy, Vol. 8, Núm. 1, pp. 42-59

  5. Increased miR-21-3p and miR-487b-3p serum levels during anaphylactic reaction in food allergic children

    Pediatric Allergy and Immunology, Vol. 32, Núm. 6, pp. 1296-1306

  6. Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs

    Frontiers in Pharmacology, Vol. 12

  7. Polymorphisms in eicosanoid-related biosynthesis enzymes associated with acute urticaria/angioedema induced by nonsteroidal anti-inflammatory drug hypersensitivity

    British Journal of Dermatology, Vol. 185, Núm. 4, pp. 815-824

  8. Proteomic and Biological Analysis of an In Vitro Human Endothelial System in Response to Drug Anaphylaxis

    Frontiers in Immunology, Vol. 12

  9. Proteomic profile of extracellular vesicles in anaphylaxis and their role in vascular permeability

    Allergy: European Journal of Allergy and Clinical Immunology

  10. The Role of Basophil Activation Test in Drug Allergy

    Current Treatment Options in Allergy, Vol. 8, Núm. 4, pp. 298-313

2020

  1. Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review—An EAACI position paper

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1069-1098

  2. Hypersensitivity Reactions to Multiple Iodinated Contrast Media

    Frontiers in Pharmacology, Vol. 11

  3. Recommendations for Diagnosing and Management of Patients with Perioperative Drug Reactions

    Current Treatment Options in Allergy, Vol. 7, Núm. 2, pp. 181-197

  4. The TNF-like weak inducer of the apoptosis/fibroblast growth factor–inducible molecule 14 axis mediates histamine and platelet-activating factor–induced subcutaneous vascular leakage and anaphylactic shock

    Journal of Allergy and Clinical Immunology, Vol. 145, Núm. 2, pp. 583-596.e6